The U.S. Food and Drug Administration has classified a corrective action involving insulin pumps from Tandem Diabetes Care ...

Early proof-of-concept study showed that a patch pump with integrated glucose sensing at the site of insulin delivery can ...

Including continuous glucose monitors (CGMs) and insulin pumps in the next round of Medicare’s competitive bidding program ...

A malfunction may cause insulin delivery to stop. Tandem instructed users to update their pump software as soon as possible.

Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.

The US Food and Drug Administration (FDA) has issued a Class I recall for the t:connect mobile app on iOS, which is used to monitor and control the t:slim X2 insulin pump used by people with diabetes.

As technology becomes more integrated and personalized, experts say the biggest opportunity in diabetes management is ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technology is now fully ...

Report OverviewThe global insulin pumps market is projected to grow at a rate of 12% by 2028, fueled by rising diabetes ...

As quantum computers advance, they are expected to be able to break tried-and-true security schemes that currently keep most ...